Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

The Karnataka government declared 14 drugs manufactured by different companies “substandard” on 25 June 2025, and warned ...

KA Gov Flags 14 Drugs As Sub-Standard directs chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

A spate of mid-flight illnesses on a recent Air India London–Mumbai service has cast a harsh light on airline catering ...

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.

Zepto has been stirring controversy over allegations of food safety violations and mistreatment of delivery partners.

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in ...

The US FDA issued a Form 483 observation for its Telangana API facility. While not a final non-compliance verdict, the ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for prucalopride ...